Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Anthem Biosciences Ltd

NSE: ANTHEM · BSE: 544449 · Pharmaceuticals & Biotechnology · 31 announcements

Share price
₹890.35
Market cap
₹50,144 Cr
Revenue (annual)
₹2,124 Cr
Net profit (annual)
₹591.8 Cr
P/E (TTM)
87.1×Sector 47.4×
Promoter holding
71.42%-3.26% QoQ
FII holding
2.57%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:53 IST NSE
Financial Results

Anthem Biosciences Q4 FY26 Results: Net Profit ₹189.8 Cr, Up 129.8% YoY

Anthem Biosciences Ltd reported revenue from operations of ₹610.9 Cr (+26.4% YoY) and net profit of ₹189.8 Cr (+129.8% YoY) for Q4 FY26.

Key figure
Net profit ₹189.8 Cr · +129.8% YoY
18:51 IST NSE
Financial Results

Anthem Biosciences Financial Results

Anthem Biosciences Limited approved its audited annual financial results for fiscal year 2026. The Board also recommended a final dividend of ₹2.00 per share.